A Study Of Augmented Reality Real-Time Guidance With In-situ Feedback

ConditionsBiopsyAblation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-90
SponsorMayo Clinic

About this trial

The purpose of this study is to evaluate the feasibility and safety of using the LUMENA guidance system during clinical procedures in patients undergoing CT-guided needle Placement for kidney, liver, lymph node, abdominal mass and lung ablation/biopsy.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Provision of signed and dated informed consent form

Stated willingness to comply with all study procedures and availability for the duration of the study

Male or female, ages 18-90 years

Patient referred to Interventional Radiology for CT-guided needle placement for ablation/biopsy.

Disqualifiers

Patients who are unable to give informed consent themselves or through their parents.

Patients that do not fit into the gantry of the CT scanner.

Patients who are sensitive to radiation exposure such as pregnant women.

Trial design

Design model

Single group

Treatments tested in this trial

  • LUMENA Guidance System

    Device

    LUMENA is an augmented reality needle guidance system that provides real-time visual guidance during CT-guided needle placement procedures.

Treatment groups

10 Participants
are divided into 1 treatment group
Group A: LUMENA Augmented Reality GuidanceExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Feasibility of completing the CT-guided needle placement procedure using the LUMENA guidance system

Feasibility will be assessed as the proportion of procedures successfully completed using the LUMENA guidance system without withdrawal of the system before completion. The procedure will be considered feasible if more than 80% of procedures are completed using the system.

Time frame
2 years
2

Safety of CT-guided needle placement using the LUMENA guidance system as assessed by adverse events

Safety will be assessed by the occurrence of serious adverse events and total adverse events associated with the procedure. The safety endpoint is safe needle placement in the target without any serious adverse events and total adverse events less than 10%.

Time frame
2 years

Secondary outcomes

1

Accuracy of needle placement

Needle placement accuracy will be assessed by comparing the planned target location on the planning CT image set with the actual needle tip location on the confirmatory CT image set. Accuracy will be calculated as the three-dimensional distance between the planned target and actual needle tip location, reported in millimeters.

Time frame
1 day
2

Procedure time

Procedure time will be measured from acquisition of the initial imaging to acquisition of the final imaging and reported in minutes.

Time frame
1 day
3

Number of intermediary CT/fluoroscopy images

The number of intermediary CT/fluoroscopy images obtained during the procedure will be recorded as an indirect measure of radiation exposure.

Time frame
1 day
4

Operator usability assessment of the LUMENA guidance system

At the end of each procedure, the operator will complete a usability form that captures ease of use using a Likert scale and subjective clinical impressions of system use and utility.

Time frame
1 day

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.